Ameneh Khatami is a senior lecturer in Child and Adolescent Health for The University of Sydney, based at The Children’s Hospital at Westmead where she also works as a paediatric infectious diseases physician. Her research focus is on novel therapeutic options for difficult to treat infections (including phage therapy) and optimisation of antimicrobial therapy for children with cystic fibrosis. She was the first clinician in Australia to treat a child with intravenous phage therapy in October 2019 for a highly resistant Pseudomonas aeruginosa bone infection and has been overseeing the planning and treatment of other patients using phages against Mycobacterium abscessus (including the first use of a genetically modified phage in Australia) through collaborations with the Westmead Institute for Medical Research and The Sydney Children’s Hospital Network cystic fibrosis team. Ameneh is the paediatric representative for the Australasian Society for Infectious Diseases Clinical Research Network with a goal to increase involvement of children in clinical trials, particularly early phase studies.